Lista de obras - Suzanne Nielsen - Dominio Público Uruguay

'Extreme personal stress' and 'a lot of pain': Exploring the physical, mental and social contexts of extramedical pharmaceutical opioid use in Australian paramedic case descriptions

artículo científico publicado en 2020

A comparison of buprenorphine taper outcomes between prescription opioid and heroin users

artículo científico publicado en 2013

A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs

artículo científico publicado en 2013

A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes

artículo científico publicado en 2012

A synthesis of oral morphine equivalents (OME) for opioid utilisation studies

artículo científico publicado en 2015

Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study.

artículo científico publicado en 2015

An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia

artículo científico publicado en 2015

Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication.

artículo científico publicado en 2017

Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization

artículo científico publicado en 2014

Benzodiazepines

artículo científico publicado en 2017

Benzodiazepines, methadone and buprenorphine: interactions and clinical management

artículo científico publicado en 2010

Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users

artículo científico publicado en 2014

Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).

artículo científico publicado en 2013

Cannabinoids for the treatment of spasticity

artículo científico publicado en 2019

Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011.

artículo científico publicado en 2015

Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.

artículo científico publicado en 2011

Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends, and the effect of reformulation in Victoria, Australia from 2013-2018

scientific article published on 09 December 2020

Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study

artículo científico publicado en 2020

Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology

artículo científico publicado en 2012

Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study

artículo científico publicado en 2014

Commentary on Cairns et al. (2020): Codeine rescheduling-where to from here?

artículo científico publicado en 2019

Commentary on Chang et al. (2018): Assessing prescribing volume and patient risk-implementation considerations.

artículo científico publicado en 2018

Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world

artículo científico publicado en 2018

Comparing buprenorphine induction experience with heroin and prescription opioid users

artículo científico publicado en 2012

Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study

scientific article published on 27 May 2019

Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018

scientific article published on 18 November 2019

Comparing rates and characteristics of emergency department presentations related to pharmaceutical opioid poisoning in Australia: a study protocol for a retrospective observational study

artículo científico publicado en 2020

Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series

artículo científico publicado en 2014

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment

artículo científico publicado en 2007

Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain

scientific article published on 16 December 2019

Correlates of pain in an in-treatment sample of opioid-dependent people

artículo científico publicado en 2013

Crushing buprenorphine tablets

artículo científico publicado en 2003

Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives

scientific article published on 27 November 2019

Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale

artículo científico publicado en 2015

Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample

artículo científico publicado en 2013

Etizolam: A rapid review on pharmacology, non-medical use and harms

scientific article published on 03 April 2020

Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain

artículo científico publicado en 2015

Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia

artículo científico publicado en 2020

Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study

artículo científico publicado en 2015

How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experiment

artículo científico publicado en 2022

Impact of Removing Nonprescription Codeine in Australia: Protocol for a Prospective Cohort Study

artículo científico publicado en 2020

Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study

artículo científico publicado en 2015

Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events

artículo científico publicado en 2008

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study

artículo científico publicado en 2020

Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?

scientific article published on 09 January 2020

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

artículo científico publicado en 2017

Opportunities and challenges: over-the-counter codeine supply from the codeine consumer’s perspective

artículo científico publicado en 2012

Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between.

artículo científico publicado en 2016

Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia

artículo científico publicado en 2019

Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: Findings from a cross-sectional study in three Australian cities

artículo científico publicado en 2020

Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort.

artículo científico publicado en 2015

Pharmaceutical drugs: The delicate balance between reducing pain and reducing harm

artículo científico publicado en 2011

Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?

artículo científico publicado en 2011

Prescription drug abuse: from epidemiology to public policy

artículo científico publicado en 2014

Recent trends in heroin and pharmaceutical opioid-related harms in Victoria, Australia up to 2018

scientific article published on 02 December 2019

Selective review and commentary on emerging pharmacotherapies for opioid addiction

artículo científico publicado en 2011

Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases.

artículo científico publicado en 2010

Sleep Quality Among People Living With Chronic Noncancer Pain: Findings From the Pain and Opioids IN Treatment (POINT) Cohort

artículo científico publicado en 2015

The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain.

artículo científico publicado en 2015

The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews

artículo científico publicado en 2018

The effect of buprenorphine and benzodiazepines on respiration in the rat.

artículo científico publicado en 2005

The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence

artículo científico publicado en 2010

The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample

artículo científico publicado en 2013

The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids.

artículo científico publicado en 2013

The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids

artículo científico publicado en 2015

Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia.

artículo científico publicado en 2015

Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories

scientific article published on 24 September 2015

Trends and characteristics of accidental and intentional codeine overdose deaths in Australia.

artículo científico publicado en 2015

Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence

scientific article published on 02 October 2018

Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain

artículo científico publicado en 2019

What can Australia learn from the North American opioid crisis? The role of opioid regulation and other evidence-based responses

scientific article published on 01 March 2019

What factors contributed to the misconduct of health practitioners? An analysis of Australian cases involving the diversion and supply of pharmaceutical drugs for non-medical use between 2010 and 2016

scientific article published on 18 March 2019

What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy

artículo científico publicado en 2020

Lista de obras de Suzanne Nielsen

'Extreme personal stress' and 'a lot of pain': Exploring the physical, mental and social contexts of extramedical pharmaceutical opioid use in Australian paramedic case descriptions

A comparison of buprenorphine taper outcomes between prescription opioid and heroin users

A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs

A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes

A synthesis of oral morphine equivalents (OME) for opioid utilisation studies

Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study.

An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia

Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication.

Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization

Benzodiazepines

Benzodiazepines, methadone and buprenorphine: interactions and clinical management

Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users

Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).

Cannabinoids for the treatment of spasticity

Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011.

Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.

Characteristics of oxycodone-related ambulance attendances: analysis of temporal trends, and the effect of reformulation in Victoria, Australia from 2013-2018

Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study

Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology

Cohort protocol paper: the Pain and Opioids In Treatment (POINT) study

Commentary on Cairns et al. (2020): Codeine rescheduling-where to from here?

Commentary on Chang et al. (2018): Assessing prescribing volume and patient risk-implementation considerations.

Commentary on McDonald et al. (2018): Intranasal naloxone-from the laboratory to the real world

Comparing buprenorphine induction experience with heroin and prescription opioid users

Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Australia: a protocol for a retrospective observational study

Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018

Comparing rates and characteristics of emergency department presentations related to pharmaceutical opioid poisoning in Australia: a study protocol for a retrospective observational study

Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case series

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment

Correlates of indicators of potential extra-medical opioid use in people prescribed opioids for chronic non-cancer pain

Correlates of pain in an in-treatment sample of opioid-dependent people

Crushing buprenorphine tablets

Designing, implementing and evaluating the overdose response with take-home naloxone model of care: An evaluation of client outcomes and perspectives

Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale

Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample

Etizolam: A rapid review on pharmacology, non-medical use and harms

Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain

Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia

Health service utilisation by people living with chronic non-cancer pain: findings from the Pain and Opioids IN Treatment (POINT) study

How do patient, pharmacist and medication characteristics and prescription drug monitoring program alerts influence pharmacists' decisions to dispense opioids? A randomised controlled factorial experiment

Impact of Removing Nonprescription Codeine in Australia: Protocol for a Prospective Cohort Study

Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study

Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events

Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: protocol for the CoLAB study

Opioid agonist treatment in the time of fentanyl: What can we learn from emerging evidence?

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis.

Opportunities and challenges: over-the-counter codeine supply from the codeine consumer’s perspective

Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between.

Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia

Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: Findings from a cross-sectional study in three Australian cities

Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort.

Pharmaceutical drugs: The delicate balance between reducing pain and reducing harm

Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?

Prescription drug abuse: from epidemiology to public policy

Recent trends in heroin and pharmaceutical opioid-related harms in Victoria, Australia up to 2018

Selective review and commentary on emerging pharmacotherapies for opioid addiction

Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases.

Sleep Quality Among People Living With Chronic Noncancer Pain: Findings From the Pain and Opioids IN Treatment (POINT) Cohort

The Pain and Opioids IN Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain.

The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews

The effect of buprenorphine and benzodiazepines on respiration in the rat.

The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence

The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample

The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids.

The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids

Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, Australia.

Treatment outcomes in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories

Trends and characteristics of accidental and intentional codeine overdose deaths in Australia.

Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence

Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain

What can Australia learn from the North American opioid crisis? The role of opioid regulation and other evidence-based responses

What factors contributed to the misconduct of health practitioners? An analysis of Australian cases involving the diversion and supply of pharmaceutical drugs for non-medical use between 2010 and 2016

What predicts pharmacists' engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy